• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康志愿者长期接受吗氯贝胺和反苯环丙胺治疗期间酪胺升压作用的测定与比较。

Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.

作者信息

Berlin I, Zimmer R, Cournot A, Payan C, Pedarriosse A M, Puech A J

机构信息

Department of Clinical Pharmacology, Hôpital Pitié-Salpétrière, Paris, France.

出版信息

Clin Pharmacol Ther. 1989 Sep;46(3):344-51. doi: 10.1038/clpt.1989.149.

DOI:10.1038/clpt.1989.149
PMID:2673623
Abstract

Monoamine oxidase inhibitors can elicit increases in systolic blood pressure after tyramine ingestion (cheese effect). Moclobemide is a new, reversible, preferential monoamine oxidase A inhibitor with antidepressant properties. Its potentiation of the tyramine pressor effect during 200 mg t.i.d. chronic treatment was compared with tranylcypromine, 10 mg b.i.d., in a double-blind, parallel-group, placebo-controlled study (n = 16). Tyramine was mixed with food and ingested in increasing daily doses, during a normal meal, until a systolic blood pressure increase of at least 30 mm Hg was achieved (tyramine 30). When compared with the usual fasting oral tyramine tests performed in the same subjects, the mean tyramine 30 dose with a meal was 2.8 times higher. The mean tyramine 30 dose with a meal decreased from 1450 mg (range, 800 to 2000 mg) during placebo to 306 mg (range, 150 to 500 mg) during moclobemide (factor, 5.0) and from 1200 mg (range, 1000 to 1600 mg) during placebo to 35 mg (range, 20 to 50 mg) during tranylcypromine (factor, 38.2). The duration of the systolic blood pressure increase was longer with tranylcypromine (126 minutes) than with moclobemide (69 minutes) (p less than 0.01).

摘要

单胺氧化酶抑制剂在摄入酪胺后可引起收缩压升高(奶酪效应)。吗氯贝胺是一种新型、可逆、选择性单胺氧化酶A抑制剂,具有抗抑郁特性。在一项双盲、平行组、安慰剂对照研究(n = 16)中,将其在200mg每日三次的慢性治疗期间对酪胺升压效应的增强作用与反苯环丙胺(10mg每日两次)进行了比较。酪胺与食物混合,在正常进餐期间以递增的每日剂量摄入,直至收缩压升高至少30mmHg(酪胺30)。与在同一受试者中进行的常规空腹口服酪胺试验相比,进餐时酪胺30的平均剂量高出2.8倍。进餐时酪胺30的平均剂量从安慰剂期间的1450mg(范围800至2000mg)降至吗氯贝胺期间的306mg(范围150至500mg)(系数为5.0),从安慰剂期间的1200mg(范围1000至1600mg)降至反苯环丙胺期间的35mg(范围20至50mg)(系数为38.2)。反苯环丙胺引起的收缩压升高持续时间(126分钟)比吗氯贝胺(69分钟)长(p<0.01)。

相似文献

1
Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.健康志愿者长期接受吗氯贝胺和反苯环丙胺治疗期间酪胺升压作用的测定与比较。
Clin Pharmacol Ther. 1989 Sep;46(3):344-51. doi: 10.1038/clpt.1989.149.
2
Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.人体内酪胺升压效应:使用新型可逆性单胺氧化酶抑制剂吗氯贝胺的研究
J Neural Transm Suppl. 1988;26:57-71.
3
Interaction between orally administered tyramine and moclobemide.口服酪胺与吗氯贝胺之间的相互作用。
Acta Psychiatr Scand Suppl. 1990;360:78-80. doi: 10.1111/j.1600-0447.1990.tb05341.x.
4
Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.酪胺增强作用与单胺氧化酶(MAO)抑制之间的关系:吗氯贝胺与其他MAO抑制剂的比较。
Acta Psychiatr Scand Suppl. 1990;360:81-3. doi: 10.1111/j.1600-0447.1990.tb05342.x.
5
Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine.新型可逆性单胺氧化酶抑制剂吗氯贝胺与口服酪胺的相互作用。
J Neural Transm Suppl. 1988;26:97-104.
6
Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.在健康男性志愿者中比较苯乙肼和吗氯贝胺治疗后酪胺的升压作用。
Clin Pharmacol Ther. 1992 Sep;52(3):286-91. doi: 10.1038/clpt.1992.143.
7
Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.酪胺升压反应与吗氯贝胺——一种可逆性单胺氧化酶抑制剂
Psychiatry Res. 1987 Nov;22(3):213-20. doi: 10.1016/0165-1781(87)90036-9.
8
Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.新型可逆性单胺氧化酶抑制剂吗氯贝胺对酪胺吸收及升压作用的影响。
J Cardiovasc Pharmacol. 1988 Jan;11(1):17-23. doi: 10.1097/00005344-198801000-00003.
9
Double-blind comparison of moclobemide and tranylcypromine in depression.吗氯贝胺与反苯环丙胺治疗抑郁症的双盲对照研究
Pharmacopsychiatry. 1993 Nov;26(6):240-5. doi: 10.1055/s-2007-1014361.
10
Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.健康受试者在接受吗氯贝胺与司来吉兰联合治疗期间的酪胺升压敏感性。
Eur J Clin Pharmacol. 1996;49(4):273-8. doi: 10.1007/BF00226327.

引用本文的文献

1
The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles.《MAOI 饮食指南——解决酪胺烦恼》。
Psychopharmacol Bull. 2022 May 31;52(2):73-116.
2
The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.经典单胺氧化酶抑制剂诱导自发性高血压的痕量胺理论。
J Neural Transm (Vienna). 2021 Nov;128(11):1741-1756. doi: 10.1007/s00702-021-02399-9. Epub 2021 Aug 9.
3
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.
重新评估单胺氧化酶抑制剂的安全性概况:阐明陈旧的酪胺神话。
J Neural Transm (Vienna). 2018 Nov;125(11):1707-1717. doi: 10.1007/s00702-018-1932-y. Epub 2018 Sep 25.
4
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.吗氯贝胺和苯乙肼对单胺氧化酶 -A 的占有率:对单胺氧化酶抑制剂开发的启示
Int J Neuropsychopharmacol. 2015 Aug 27;19(1):pyv078. doi: 10.1093/ijnp/pyv078.
5
Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties.吗氯贝胺:演变、药效学及药代动力学特性
CNS Drug Rev. 2002 Fall;8(3):283-308. doi: 10.1111/j.1527-3458.2002.tb00229.x.
6
Clinically significant drug interactions with antidepressants in the elderly.老年人中与抗抑郁药具有临床意义的药物相互作用。
Drugs Aging. 2002;19(4):299-320. doi: 10.2165/00002512-200219040-00004.
7
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.吗氯贝胺对健康志愿者中5-HT1B/1D激动剂利扎曲普坦药代动力学的影响。
Br J Clin Pharmacol. 1999 Aug;48(2):190-6. doi: 10.1046/j.1365-2125.1999.00011.x.
8
Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.单胺氧化酶-A抑制剂吗氯贝胺的临床药代动力学
Clin Pharmacokinet. 1995 Nov;29(5):292-332. doi: 10.2165/00003088-199529050-00002.
9
Comparative tolerability profiles of the newer versus older antidepressants.新型抗抑郁药与传统抗抑郁药的耐受性比较
Drug Saf. 1994 Jan;10(1):18-46. doi: 10.2165/00002018-199410010-00003.
10
Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects.健康受试者中酒精与吗氯贝胺或氯米帕明相互作用的评估与比较。
Psychopharmacology (Berl). 1990;100(1):40-5. doi: 10.1007/BF02245787.